JP2018507690A5 - - Google Patents

Download PDF

Info

Publication number
JP2018507690A5
JP2018507690A5 JP2017544332A JP2017544332A JP2018507690A5 JP 2018507690 A5 JP2018507690 A5 JP 2018507690A5 JP 2017544332 A JP2017544332 A JP 2017544332A JP 2017544332 A JP2017544332 A JP 2017544332A JP 2018507690 A5 JP2018507690 A5 JP 2018507690A5
Authority
JP
Japan
Prior art keywords
bone marrow
composition
marrow cells
mitochondrial
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017544332A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018507690A (ja
JP7015169B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2016/050205 external-priority patent/WO2016135723A1/en
Publication of JP2018507690A publication Critical patent/JP2018507690A/ja
Publication of JP2018507690A5 publication Critical patent/JP2018507690A5/ja
Priority to JP2021142214A priority Critical patent/JP7263455B2/ja
Application granted granted Critical
Publication of JP7015169B2 publication Critical patent/JP7015169B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017544332A 2015-02-26 2016-02-24 機能性ミトコンドリアで富化された哺乳動物細胞 Active JP7015169B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021142214A JP7263455B2 (ja) 2015-02-26 2021-09-01 機能性ミトコンドリアで富化された哺乳動物細胞

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562120907P 2015-02-26 2015-02-26
US62/120,907 2015-02-26
PCT/IL2016/050205 WO2016135723A1 (en) 2015-02-26 2016-02-24 Mammalian cells enriched with functional mitochondria

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021142214A Division JP7263455B2 (ja) 2015-02-26 2021-09-01 機能性ミトコンドリアで富化された哺乳動物細胞

Publications (3)

Publication Number Publication Date
JP2018507690A JP2018507690A (ja) 2018-03-22
JP2018507690A5 true JP2018507690A5 (enExample) 2019-04-04
JP7015169B2 JP7015169B2 (ja) 2022-02-02

Family

ID=56789318

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017544332A Active JP7015169B2 (ja) 2015-02-26 2016-02-24 機能性ミトコンドリアで富化された哺乳動物細胞
JP2021142214A Active JP7263455B2 (ja) 2015-02-26 2021-09-01 機能性ミトコンドリアで富化された哺乳動物細胞

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021142214A Active JP7263455B2 (ja) 2015-02-26 2021-09-01 機能性ミトコンドリアで富化された哺乳動物細胞

Country Status (5)

Country Link
US (3) US20180030413A1 (enExample)
EP (1) EP3261649A4 (enExample)
JP (2) JP7015169B2 (enExample)
IL (2) IL254071B2 (enExample)
WO (1) WO2016135723A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL282198B2 (en) 2011-09-11 2025-11-01 Minovia Therapeutics Ltd Compositions of functional mitochondria and uses thereof
CA2952121A1 (en) 2014-06-13 2015-12-17 Childrens' Medical Center Corporation Products and methods to isolate mitochondria
US20170151287A1 (en) 2015-11-30 2017-06-01 Flagship Ventures Management, Inc. Methods and compositions of chondrisomes
ES3057779T3 (en) 2016-01-15 2026-03-04 Childrens Medical Ct Corp Therapeutic use of mitochondria and combined mitochondrial agents
WO2018088874A1 (ko) * 2016-11-14 2018-05-17 주식회사 파이안바이오테크놀로지 외래 미토콘드리아를 세포로 전달하는 방법
CN109983120A (zh) 2016-11-14 2019-07-05 白雁生物技术公司 含有外源线粒体的天然杀伤细胞和含有其的药物组合物
CN110022884A (zh) * 2016-11-30 2019-07-16 白雁生物技术公司 含有线粒体的药物组合物
US20200023005A1 (en) * 2017-03-26 2020-01-23 Minovia Therapeutics Ltd. Mitochondrial compositions and methods for treatment of skin and hair
WO2019183042A1 (en) * 2018-03-20 2019-09-26 Unity Biotechnology, Inc. Autologous mitochondrial extraction and expansion
WO2019186553A1 (en) * 2018-03-27 2019-10-03 Minovia Therapeutics Ltd. Methods for elevation of lipid and cholesterol metabolism
WO2020021541A1 (en) * 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy with stem cells enriched with functional mitochondria
US12502408B2 (en) * 2018-07-22 2025-12-23 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy for primary mitochondrial diseases
US12329781B2 (en) 2018-07-22 2025-06-17 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of renal diseases
JP7524157B2 (ja) * 2018-07-22 2024-07-29 ミノヴィア セラピューティクス リミテッド 脳疾患のミトコンドリア増強療法
WO2020021539A1 (en) * 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of muscle diseases
EP3823644A4 (en) * 2018-07-22 2022-06-08 Minovia Therapeutics Ltd. MITOCHONDRIAL AUGMENTATION THERAPY OF PANCREATIC DISEASES
WO2020021535A1 (en) * 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of ocular diseases
WO2020021537A1 (en) * 2018-07-22 2020-01-30 Minovia Therapeutics Ltd. Mitochondrial augmentation therapy of liver diseases
KR20210045435A (ko) * 2018-08-14 2021-04-26 이멜 바이오테라퓨틱스, 인코포레이티드. 미토콘드리아 질환 또는 장애 및 헤테로플라스미를 치료하기 위한 방법 및 조성물
CN112912087A (zh) * 2018-09-14 2021-06-04 卢卡科学株式会社 线粒体向淋巴器官中的移植以及用于该移植的组合物
JP2022517784A (ja) * 2019-01-11 2022-03-10 フィジーン、エルエルシー 線維芽細胞再生細胞
JP7745544B2 (ja) * 2019-10-24 2025-09-29 イメル バイオセラピューティクス,インク. ミトコンドリアdna中のマクロヘテロプラスミー及びミクロヘテロプラスミーを検出するための方法
US12091684B2 (en) * 2020-02-14 2024-09-17 Hackensack Meridian Health, Inc. Platelet-derived mitochondria treatment and method of generating multipotent cells
TWI789723B (zh) * 2020-03-20 2023-01-11 台灣粒線體應用技術股份有限公司 粒線體用於治療或/及預防腎臟損傷相關疾病之用途
MX2022012157A (es) * 2020-03-31 2023-02-15 Minovia Therapeutics Ltd Celulas geneticamente modificadas enriquecidas con mitocondrias y usos de estas.
CN115427052A (zh) * 2020-03-31 2022-12-02 米诺维亚治疗公司 线粒体加强疗法
US20230190822A1 (en) * 2020-05-05 2023-06-22 Pluri Biotech Ltd. Methods and compositions for enrichment of target cells
AU2023304232A1 (en) * 2022-07-08 2025-01-23 Mitrix Bio, Inc. Systems and methods for growing mitochondria and coating thereof
EP4598550A1 (en) * 2022-10-06 2025-08-13 Mitrix Bio, Inc. Formulations and methods for cellular therapies involving chimeric antigen receptors
CN116478920B (zh) * 2023-05-05 2025-03-25 重庆理工大学 一种离体线粒体的体外储存方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003012050A2 (en) 2001-07-31 2003-02-13 Northeastern University Mitochondrial genome replenishment
US20050153381A1 (en) * 2002-02-14 2005-07-14 Marusich Michael F. Immunocapture of mitochondrial protein complexes
AU2004238375A1 (en) 2003-05-13 2004-11-25 The Regents Of The University Of Colorado Diagnostic and therapeutic treatments related to mitochondrial disorders
US7407800B1 (en) 2003-09-19 2008-08-05 Pierce Biotechnology, Inc. Method for the isolation of intact mitochondria from cells
CA2688125A1 (en) 2007-05-02 2008-11-13 The Mclean Hospital Corporation Methods and compositions for mitochondrial replacement therapy
WO2008152640A2 (en) 2007-06-13 2008-12-18 Pluristem Ltd. Three dimensional biocompatible scaffolds for ex-vivo expansion and transplantation of stem cells
WO2009154770A2 (en) 2008-06-18 2009-12-23 The Texas A & M University System Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage
US20110105359A1 (en) 2009-10-30 2011-05-05 Xenotech, Llc Cryopreservation of cells and subcellular fractions
US8338178B2 (en) 2010-10-28 2012-12-25 The Invention Science Fund I, Llc Mitochondrial enhancement of cells
EP2726601B1 (en) 2011-06-29 2018-12-26 The General Hospital Corporation Compositions and methods for enhancing bioenergetic status in female germ cells
US20130022666A1 (en) * 2011-07-20 2013-01-24 Anna Brzezinska Methods and compositions for transfer of mitochondria into mammalian cells
IL282198B2 (en) * 2011-09-11 2025-11-01 Minovia Therapeutics Ltd Compositions of functional mitochondria and uses thereof
US8648034B2 (en) * 2011-12-09 2014-02-11 Changhua Christian Hospital Method and applications of peptide-mediated mitochondrial delivery system
WO2013149064A1 (en) * 2012-03-30 2013-10-03 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Uridine diphosphate compounds as mobilizers of hematopoietic progenitor cells
US10702556B2 (en) 2012-05-16 2020-07-07 Minovia Therpautices Ltd. Compositions and methods for inducing angiogenesis
WO2016008937A1 (en) * 2014-07-16 2016-01-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for the intercellular transfer of isolated mitochondria in recipient cells

Similar Documents

Publication Publication Date Title
Chen et al. Improvement of impaired motor functions by human dental exfoliated deciduous teeth stem cell-derived factors in a rat model of Parkinson’s disease
Zhou et al. Nicotine deteriorates the osteogenic differentiation of periodontal ligament stem cells through α7 nicotinic acetylcholine receptor regulating Wnt pathway
Lopes-Coelho et al. Monocytes as endothelial progenitor cells (EPCs), another brick in the wall to disentangle tumor angiogenesis
Belyavsky et al. Hematopoiesis during ontogenesis, adult life, and aging
White et al. Intrinsic cardiac origin of human cardiosphere-derived cells
Ehrlich et al. Differential evolution of the epidermal keratin cytoskeleton in terrestrial and aquatic mammals
Zhu et al. MSCs alleviate LPS-induced acute lung injury by inhibiting the proinflammatory function of macrophages in mouse lung organoid–macrophage model
Ozekin et al. Single cell sequencing of the mouse anterior palate reveals mesenchymal heterogeneity
Niu et al. Transcriptional profiling of interleukin-2-primed human adipose derived mesenchymal stem cells revealed dramatic changes in stem cells response imposed by replicative senescence
Durand et al. Effect of comedications and endotoxins on mesenchymal stem cell secretomes, migratory and immunomodulatory capacity
Mendes et al. Transforming the niche: the emerging role of extracellular vesicles in acute myeloid leukaemia progression
Lettieri et al. The plastic interplay between lung regeneration phenomena and fibrotic evolution: current challenges and novel therapeutic perspectives
Santos et al. Intrinsic angiogenic potential and migration capacity of human mesenchymal stromal cells derived from menstrual blood and bone marrow
Watt et al. Heterogeneity in pancreatic cancer fibroblasts—tgfβ as a master regulator?
Cao et al. Characterization of the role of amylo-alpha-1, 6-glucosidase protein in the infectivity of Toxoplasma gondii
Brügger et al. Pulmonary mesenchymal stem cells are engaged in distinct steps of host response to respiratory syncytial virus infection
Liu et al. Bone marrow is a reservoir for cardiac resident stem cells
Xing et al. Stem cells from human exfoliated deciduous teeth rejuvenate the liver in naturally aged mice by improving ribosomal and mitochondrial proteins
McDonald et al. Stem cell-derived extracellular vesicles in the treatment of cardiovascular diseases
Bertelsen et al. Are endothelial outgrowth cells a potential source for future re-vascularization therapy?
Nakashima et al. POT1a deficiency in mesenchymal niches perturbs B-lymphopoiesis
Forte et al. Ex uno, plures–from one tissue to many cells: a review of single-cell transcriptomics in cardiovascular biology
Friis et al. Comparison of mesenchymal stromal cells from young healthy donors and patients with severe chronic coronary artery disease
Klose et al. Impact of heart failure on the behavior of human neonatal stem cells in vitro
CN105287616A (zh) 足叶乙甙联合阿糖胞苷动员技术在淋巴瘤/骨髓瘤中的应用